Business Description
Founded in 2003 and based in Austin, Texas, Natera is a global molecular diagnostics company offering a broad range of genetic tests across oncology, women's health, and organ transplantation. Its tests support patients and clinicians at critical moments, from monitoring cancer recurrence and evaluating treatment response to screening for hereditary conditions during pregnancy and assessing organ rejection after transplant. Natera distributes its services through direct sales, laboratory partners, and a cloud-based platform, and works with pharmaceutical companies and research institutions worldwide.
